Manabu Nonaka Selected Research

Kimura Disease

10/2017	Basophils are increased and express increased levels of interleukin-4 in the parotid lesions of Kimura disease.
1/2015	Increased expression of thymic stromal lymphopoietin and its receptor in Kimura's disease.
8/2014	Anti-IgE therapy to Kimura's disease: a pilot study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Manabu Nonaka Research Topics

Disease

12	Asthma (Bronchial Asthma) 01/2021 - 04/2003
10	Nasal Polyps (Nasal Polyp) 07/2011 - 12/2007
4	Rhinosinusitis 01/2021 - 02/2010
4	Inflammation (Inflammations) 10/2017 - 01/2007
3	Allergic Rhinitis 01/2018 - 07/2011
3	Kimura Disease 10/2017 - 08/2014
2	Neoplasms (Cancer) 01/2021 - 12/2014
2	Sinusitis 01/2021 - 12/2008
2	Otitis Media 01/2021 - 01/2012
2	Eosinophilia 05/2013 - 04/2003
2	Otitis Media with Effusion 06/2009 - 04/2003
1	Cerebral Infarction 08/2021
1	Mucormycosis 08/2021
1	Carotid Artery Thrombosis 08/2021
1	Mikulicz' Disease 01/2021
1	Immunoglobulin G4-Related Disease 01/2021
1	IGA Glomerulonephritis (IGA Nephropathy) 10/2019
1	Hematuria 10/2019
1	Tonsillitis 10/2019
1	Sialorrhea 01/2019
1	Constipation 01/2019
1	Bell Palsy (Bell's Palsy) 04/2018
1	Herpes Zoster Oticus (Geniculate Neuralgia) 04/2018
1	Pleomorphic Adenoma 12/2014
1	Granuloma 08/2014
1	Chronic Disease (Chronic Diseases) 08/2014
1	Hearing Loss (Hearing Impairment) 01/2012
1	Atopic Dermatitis (Atopic Eczema) 07/2011
1	Hypersensitivity (Allergy) 12/2008
1	Hyperplasia 06/2007
1	Metaplasia 06/2007
1	Labyrinth Diseases 08/2004

Drug/Important Bio-Agent (IBA)

10	CytokinesIBA 01/2021 - 01/2007
5	Immunoglobulin E (IgE)IBA 01/2021 - 01/2007
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2010 - 06/2008
4	Interleukin-4 (Interleukin 4)IBA 10/2017 - 01/2008
4	Messenger RNA (mRNA)IBA 12/2014 - 06/2008
4	Chemokine CCL17IBA 07/2011 - 06/2008
3	Omalizumab (Xolair)FDA Link 01/2021 - 01/2012
3	anti-IgE antibodiesIBA 01/2021 - 01/2012
3	Proteins (Proteins, Gene)FDA Link 10/2019 - 12/2008
3	Thymic Stromal LymphopoietinIBA 01/2015 - 01/2010
3	Fluticasone (Cutivate)FDA LinkGeneric 05/2013 - 02/2010
3	Adrenal Cortex Hormones (Corticosteroids)IBA 05/2013 - 02/2010
3	LigandsIBA 03/2010 - 12/2007
2	SteroidsIBA 10/2019 - 01/2012
2	Monoclonal AntibodiesIBA 08/2014 - 01/2012
2	Poly I-CIBA 01/2010 - 06/2009
2	Interleukin-5 (Interleukin 5)IBA 12/2008 - 04/2003
1	ParaffinIBA 08/2021
1	Cytidine DeaminaseIBA 01/2021
1	Immunoglobulin G (IgG)IBA 01/2021
1	CreatinineIBA 10/2019
1	Muscarinic M3 ReceptorIBA 01/2019
1	Solifenacin Succinate FDA Link 01/2019
1	PirenzepineIBA 01/2019
1	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 01/2019
1	Cholinergic Antagonists (Anticholinergics)IBA 01/2019
1	SymportersIBA 12/2014
1	Salmeterol Xinafoate (Serevent)FDA Link 05/2013
1	Chemokine CCL22IBA 07/2011
1	Toll-Like Receptors (Toll-Like Receptor)IBA 03/2010
1	Leukotriene Antagonists (Leukotriene Receptor Antagonists)IBA 02/2010
1	montelukast (Singulair)FDA Link 02/2010
1	Macrophage Inflammatory Proteins (Macrophage Inflammatory Protein 1)IBA 10/2009
1	Interleukin-17 (Interleukin 17)IBA 10/2009
1	Toll-Like Receptor 2IBA 12/2008
1	Chemotactic FactorsIBA 06/2008
1	CC ChemokinesIBA 12/2007
1	CollagenIBA 06/2007
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2007
1	AntigensIBA 08/2004
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 08/2004

Therapy/Procedure

6	Therapeutics 01/2021 - 01/2012
2	Respiratory Therapy (Therapy, Respiratory) 01/2020 - 01/2018
1	Tonsillectomy 10/2019
1	Decompression 04/2018
1	Aftercare (After-Treatment) 02/2010